4Accepted Aug 31, 4:07 PM ET
Estee Lauder (EL) Exec VP Roberto Canevari Receives Equity Awards
Accepted (ET)
4:07 PM
Aug 31, 2026
Filed
Aug 31, 2026
Documents
1
Size
8.6 KB
Summary
Estee Lauder (EL) Exec VP Roberto Canevari Receives Equity Awards
What Happened
Roberto Canevari, Executive Vice President & CVCO of Estee Lauder (EL), received two equity awards on August 27, 2026: 8,869 restricted stock units (RSUs) and 32,320 stock option awards. No cash was exchanged at grant (price N/A); these are compensation awards/derivative grants rather than open-market purchases or sales. The RSUs vest in three approximately equal installments and will be settled in shares; the options vest/become exercisable in tranches starting November 1, 2027.
Key Details
- Transaction date: August 27, 2026 (Form 4 filed August 31, 2026).
- Awards:
- 8,869 RSUs (derivative award). Vesting schedule: 2,956 shares on Nov 1, 2027; 2,956 on Nov 1, 2028; 2,957 on Nov 1, 2029 (F3). RSUs convert one-for-one to Class A shares at payout and include dividend-equivalent cash payments (F1). Shares may be withheld to cover taxes at payout (F1).
- 32,320 stock options granted under The Estee Lauder Companies Inc. Amended and Restated Fiscal 2002 Share Incentive Plan. Options exercisable: 10,773 on/after Nov 1, 2027; 10,773 on/after Nov 1, 2028; 10,774 on/after Nov 1, 2029 (F4).
- Price/value: N/A for grant awards; grant values not specified in the filing.
- Shares owned after transaction: Not disclosed in the provided filing data.
- Notable footnotes: RSUs paid in shares and include dividend equivalents; shares withheld for statutory tax obligations; option plan cited (F1, F3, F4).
- Filing timing: Transaction dated Aug 27; Form 4 filed Aug 31 — filing date is four days after the transaction date (check regulatory timeliness requirements if relevant).
Context: These are compensation grants (awards and option grants) rather than open-market buys or sales. RSUs will convert to shares only upon vesting and payout; options must be exercised after they become exercisable to convert into shares. Such grants are routine executive compensation and do not by themselves indicate immediate buying or selling of stock.